- Bacterial Toxin Implicated In Young Adult Colon Cancers
- Exposure Therapy For Peanut Allergy Effective In Adults
- Program Matches Breast Cancer Patients To Exercise, Rehab
- AI Predicts Wasting Syndrome In Cancer Patients
- Ready-Made Immune Therapy Effective Against Leukemia
- Ultra-Processed Foods Increase Risk Of Early Death
- Head Injuries Are a Growing Risk for Anesthesiologists, Experts Warn
- Where Have All The Insects Gone — And Why?
- HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
- Novavax COVID Vaccine Moves Closer to Full FDA Approval
Health Highlights: Jan. 29, 2020

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
FDA Tells Purell Maker to Stop Making False Claims
The maker of Purell hand sanitizers has been warned by the U.S. Food and Drug Administration to stop claiming that the products can protect people from infections and illnesses.
The agency warned Gojo Industries that unsubstantiated claims that Purell can help prevent illnesses such as the flu, Ebola virus, norovirus and the MRSA superbug violate federal laws, The New York Times reported Tuesday.
Purell will be reclassified as an unapproved drug, rather than an over-the-counter product, the FDA said.
In its warning letter to Gojo, the FDA made note of unproven claims on the company’s websites and social media accounts, including “Purell Products are proven to reduce absenteeism” and Purell “kills more than 99.99 percent of the most common germs that may cause illness in a healthcare setting, including MRSA,” The Times reported.
The agency also criticized Gojo’s “Frequently Asked Questions,” which it said suggested that because Purell is made with ethyl alcohol, it might be effective against viruses like Ebola, norovirus and influenza.
Copyright © 2025 HealthDay. All rights reserved.